Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Application for Participation in Food and Drug Administration Fellowship and Traineeship Programs, 82488-82489 [2020-27963]
Download as PDF
<![CDATA[
82488
Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices
ANNUAL BURDEN ESTIMATES
Total number
of
respondents
Instrument
RFP and Contract ................................................................
Emergency Funding Request ..............................................
Biennial Reports ...................................................................
Advance Planning Document ..............................................
Operational Advance Planning Document ...........................
Independent Verification and Validation (ongoing) ..............
Independent Verification and Validation (semiannually) .....
Independent Verification and Validation (quarterly) ............
System Certification .............................................................
Estimated Total Annual Burden
Hours: 9,158.50.
Authority: 45 CFR part 95, subpart F.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–27916 Filed 12–17–20; 8:45 am]
BILLING CODE 4184–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1072]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Application for
Participation in Food and Drug
Administration Fellowship and
Traineeship Programs
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing that a proposed collection
of information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Submit written comments
(including recommendations) on the
SUMMARY:
Total number
of
responses per
respondent
Average burden hours per
response
4.5
1
1.5
3.6
3
12
6
12
3
4
2
1.5
120
30
10
16
30
240
50
21
54
44
10
3
4
10
3
collection of information by January 19,
2021.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be submitted to https://
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
Review—Open for Public Comments’’ or
by using the search function. The OMB
control number for this information
collection is 0910–0780. Also include
the FDA docket number found in
brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Amber Sanford, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–8867, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Application for Participation in FDA
Fellowship and Traineeship Programs
OMB Control Number 0910–0780—
Revision
Sections 1104, 1302, 3301, 3304,
3320, 3361, 3393, and 3394 of Title 5 of
Total burden
hours
900
42
121.5
19,008
900
360
384
3,600
2,160
Annual burden
hours
300
14
40.5
6,336
300
120
128
1,200
720
the United States Code authorize
Federal Agencies to rate applicants for
Federal jobs. The proposed information
collection involves brief online
applications completed by applicants
applying to FDA’s Fellowship and
Traineeship programs. These voluntary
online applications will allow the
Agency to easily and efficiently elicit
and review information from students
and healthcare professionals who are
interested in becoming involved in
FDA-wide activities. The process will
reduce the time and cost of submitting
written documentation to the Agency
and lessen the likelihood of applications
being misrouted within the Agency mail
system. It will assist the Agency in
promoting and protecting the public
health by encouraging outside persons
to share their expertise with FDA.
In the Federal Register of October 19,
2018 (83 FR 53065), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. Although one comment
was received, it was not responsive to
the four collection of information topics
solicited and therefore will not be
discussed in this document.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
Number of
respondents
khammond on DSKJM1Z7X2PROD with NOTICES
Activity
Number of
responses per
respondent
Total annual
responses
Average
burden per
response
Total hours
Medical Device Fellowship Program ...................................
FDA Traineeship Program ...................................................
Reagan-Udall Fellowship at FDA ........................................
250
1,000
50
1
1
1
250
1,000
50
1
1
1
250
1,000
50
Total ..............................................................................
........................
........................
........................
........................
1,300
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Sep<11>2014
22:22 Dec 17, 2020
Jkt 253001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
E:\FR\FM\18DEN1.SGM
18DEN1
Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices
Because FDA is developing two new
training programs, Trainee Program and
Reagan-Udall Fellowship, our estimated
burden for the information collection
reflects an overall increase of 2 hours.
FDA has removed the Commissioner’s
Fellowship Program and Regulatory
Science Internship Program from this
information collection as these
programs have been discontinued.
FDA published a 30-day notice for
this information collection on February
3, 2020 (85 FR 5966). FDA is reopening
the 30-day comment period in order to
satisfy PRA requirements. No changes
have been made to the information
collection.
Dated: December 14, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2020–27963 Filed 12–17–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–N–1359]
Sugars That Are Metabolized
Differently Than Traditional Sugars;
Extension of Comment Period
AGENCY:
Food and Drug Administration,
HHS.
Notification; extension of
comment period.
ACTION:
The Food and Drug
Administration (FDA or we) is
extending the comment period for the
notice entitled ‘‘Sugars that Are
Metabolized Differently than Traditional
Sugars’’ that appeared in the Federal
Register of October 19, 2020. We are
taking this action in response to a
request from stakeholders to extend the
comment period to allow additional
time for interested persons to develop
and submit data, information, and/or
comments for this request for
information and comments.
DATES: FDA is extending the comment
period on the notice published October
19, 2020 (85 FR 66335). Submit either
electronic or written comments on the
notice by February 16, 2021.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before February 16,
2021. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of February 16, 2021.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
22:22 Dec 17, 2020
Jkt 253001
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2020–N–1359 for ‘‘Sugars that Are
Metabolized Differently than Traditional
Sugars.’’ Received comments, those
filed in a timely manner (see
ADDRESSES), will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m. Eastern Time,
Monday through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
82489
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ We
will review this copy, including the
claimed confidential information, in our
consideration of comments. The second
copy, which will have the claimed
confidential information redacted/
blacked out, will be available for public
viewing and posted on https://
www.regulations.gov. Submit both
copies to the Dockets Management Staff.
If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Blakeley Fitzpatrick, Office of Nutrition
and Food Labeling, Center for Food
Safety and Applied Nutrition, Food and
Drug Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–1450.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of October 19,
2020 (85 FR 66335), we published a
notice requesting information and
comments entitled ‘‘Sugars that Are
Metabolized Differently Than
Traditional Sugars.’’ This action opened
a docket with a 60-day comment period
to receive information and comments
related to the nutrition labeling of
sugars that are metabolized differently
than traditional sugars.
FDA has received a request for a 60day extension for this comment period
in order to allow additional time for
E:\FR\FM\18DEN1.SGM
18DEN1
]]>Agencies
[Federal Register Volume 85, Number 244 (Friday, December 18, 2020)]
[Notices]
[Pages 82488-82489]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27963]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-1072]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Application for
Participation in Food and Drug Administration Fellowship and
Traineeship Programs
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
that a proposed collection of information has been submitted to the
Office of Management and Budget (OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Submit written comments (including recommendations) on the
collection of information by January 19, 2021.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be submitted to https://www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under Review--Open for Public
Comments'' or by using the search function. The OMB control number for
this information collection is 0910-0780. Also include the FDA docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-8867,
[email protected].
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Application for Participation in FDA Fellowship and Traineeship
Programs
OMB Control Number 0910-0780--Revision
Sections 1104, 1302, 3301, 3304, 3320, 3361, 3393, and 3394 of
Title 5 of the United States Code authorize Federal Agencies to rate
applicants for Federal jobs. The proposed information collection
involves brief online applications completed by applicants applying to
FDA's Fellowship and Traineeship programs. These voluntary online
applications will allow the Agency to easily and efficiently elicit and
review information from students and healthcare professionals who are
interested in becoming involved in FDA-wide activities. The process
will reduce the time and cost of submitting written documentation to
the Agency and lessen the likelihood of applications being misrouted
within the Agency mail system. It will assist the Agency in promoting
and protecting the public health by encouraging outside persons to
share their expertise with FDA.
In the Federal Register of October 19, 2018 (83 FR 53065), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. Although one comment was received, it was
not responsive to the four collection of information topics solicited
and therefore will not be discussed in this document.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Recordkeeping Burden1
----------------------------------------------------------------------------------------------------------------
Number of
Activity Number of responses per Total annual Average burden Total hours
respondents respondent responses per response
----------------------------------------------------------------------------------------------------------------
Medical Device Fellowship 250 1 250 1 250
Program........................
FDA Traineeship Program......... 1,000 1 1,000 1 1,000
Reagan-Udall Fellowship at FDA.. 50 1 50 1 50
-------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 1,300
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
[[Page 82489]]
Because FDA is developing two new training programs, Trainee
Program and Reagan-Udall Fellowship, our estimated burden for the
information collection reflects an overall increase of 2 hours. FDA has
removed the Commissioner's Fellowship Program and Regulatory Science
Internship Program from this information collection as these programs
have been discontinued.
FDA published a 30-day notice for this information collection on
February 3, 2020 (85 FR 5966). FDA is reopening the 30-day comment
period in order to satisfy PRA requirements. No changes have been made
to the information collection.
Dated: December 14, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2020-27963 Filed 12-17-20; 8:45 am]
BILLING CODE 4164-01-P
